Concord Drugs Fundamentals
P/E Ratio
180.35
P/B Ratio
2.21
Div. Yield
0
Sector P/E
61.58
Sector P/B
2.71
Sec. Div. Yield
0.58
Concord Drugs Fundamentals is currently trading with a P/E Ratio of 180.35, compared to the sector average of 61.58. Its P/B Ratio stands at 2.21, while the sector’s is 2.71. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 0.58%.
Concord Drugs Score Card
Price
Expensive
Growth
Good
Quality
Poor
Management
Poor
On its scorecard, Concord Drugs reflects: Price – Expensive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.
